Iovance Biotherapeutics Stock (NASDAQ: IOVA) stock price, news, charts, stock research, profile.
Open | $11.900 |
Close | - |
Volume / Avg. | 1.167M / 8.814M |
Day Range | 11.690 - 12.490 |
52 Wk Range | 3.210 - 18.330 |
Market Cap | $3.324B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 17.93% |
Days to Cover | 8.66 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Iovance Biotherapeutics (NASDAQ: IOVA) through any online brokerage.
Other companies in Iovance Biotherapeutics’s space includes: Immunovant (NASDAQ:IMVT), IDEAYA Biosciences (NASDAQ:IDYA), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and Alkermes (NASDAQ:ALKS).
The latest price target for Iovance Biotherapeutics (NASDAQ: IOVA) was reported by Piper Sandler on Thursday, March 14, 2024. The analyst firm set a price target for 19.00 expecting IOVA to rise to within 12 months (a possible 53.54% upside). 44 analyst firms have reported ratings in the last year.
The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $12.375 last updated Today at April 30, 2024 at 11:08 AM EDT.
There are no upcoming dividends for Iovance Biotherapeutics.
Iovance Biotherapeutics’s Q1 earnings are confirmed for Tuesday, May 14, 2024.
There is no upcoming split for Iovance Biotherapeutics.
Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.